| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1051547199 |
| P356 | DOI | 10.1203/00006450-200112000-00021 |
| P698 | PubMed publication ID | 11726736 |
| P5875 | ResearchGate publication ID | 11628613 |
| P50 | author | Eloisa Gitto | Q47238845 |
| Giuseppe Trimarchi | Q59208736 | ||
| Małgorzata Karbownik-Lewińska | Q64295767 | ||
| Russel J Reiter | Q89645924 | ||
| P2093 | author name string | Barberi I | |
| Tan DX | |||
| Chiurazzi P | |||
| Corona G | |||
| Cuzzocrea S | |||
| Cordaro S | |||
| P2860 | cites work | Sepsis and septic shock: pro-inflammatory or anti-inflammatory state? | Q33840114 |
| Significance of melatonin in antioxidative defense system: reactions and products | Q33909992 | ||
| Clinical trials of controlled-release melatonin in children with sleep-wake cycle disorders | Q33914514 | ||
| Melatonin induces gamma-glutamylcysteine synthetase mediated by activator protein-1 in human vascular endothelial cells | Q40924153 | ||
| Pharmacological actions of melatonin in oxygen radical pathophysiology | Q41508342 | ||
| Utility of high doses of melatonin as adjunctive anticonvulsant therapy in a child with severe myoclonic epilepsy: two years' experience | Q48588853 | ||
| Randomized, double-blind clinical trial, controlled with placebo, of the toxicology of chronic melatonin treatment | Q48710485 | ||
| Melatonin administration prevents lipopolysaccharide‐induced oxidative damage in phenobarbital‐treated animals | Q54607577 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | melatonin | Q180912 |
| sepsis | Q183134 | ||
| P304 | page(s) | 756-760 | |
| P577 | publication date | 2001-12-01 | |
| P1433 | published in | Pediatric Research | Q7159215 |
| P1476 | title | Effects of melatonin treatment in septic newborns | |
| P478 | volume | 50 |
| Q42381935 | 'Chronomics' in ICU: circadian aspects of immune response and therapeutic perspectives in the critically ill. |
| Q90053000 | A Novel Diagnostic Marker for the Severity of Bronchopulmonary Dysplasia in Very Low Birth Weight Infants: Interleukin-33 |
| Q22306049 | A Review of the Multiple Actions of Melatonin on the Immune System |
| Q38020932 | A review of the molecular aspects of melatonin's anti-inflammatory actions: recent insights and new perspectives. |
| Q90235916 | A solution based on melatonin, tryptophan, and vitamin B6 (Melamil Tripto©) for sedation in newborns during brain MRI |
| Q38212332 | A systematic review of peri-operative melatonin. |
| Q33442732 | Administration of Exogenous Melatonin After the Onset of Systemic Inflammation Is Hardly Beneficial |
| Q58613664 | Altered endotoxin responsiveness in healthy children with Down syndrome |
| Q44380567 | Altered neutrophil apoptosis activity is reversed by melatonin in liver ischemia-reperfusion |
| Q24187264 | Alternative lipid emulsions versus pure soy oil based lipid emulsions for parenterally fed preterm infants |
| Q92535546 | An Assessment of Melatonin's Therapeutic Value in the Hypoxic-Ischemic Encephalopathy of the Newborn |
| Q37449701 | Antenatal melatonin as an antioxidant in human pregnancies complicated by fetal growth restriction--a phase I pilot clinical trial: study protocol |
| Q38209930 | Antioxidant strategies and respiratory disease of the preterm newborn: an update |
| Q24622152 | Antioxidants that protect mitochondria reduce interleukin-6 and oxidative stress, improve mitochondrial function, and reduce biochemical markers of organ dysfunction in a rat model of acute sepsis |
| Q36847028 | Association between Pre-Transplant Serum Malondialdehyde Levels and Survival One Year after Liver Transplantation for Hepatocellular Carcinoma |
| Q36828650 | Association between total antioxidant capacity and mortality in ischemic stroke patients |
| Q51730360 | Association of Melatonin Production with Seasonal Changes, Low Temperature, and Immuno-Responses in Hamsters. |
| Q38169987 | Bench to cribside: the path for developing a neuroprotectant |
| Q47346556 | Beneficial effect of melatonin in the treatment of neonatal sepsis. |
| Q50126244 | Burn-Induced Multiple Organ Injury and Protective Effect of Lutein in Rats |
| Q40950060 | Can melatonin be used as a marker for neonatal sepsis? |
| Q99575524 | Central and Peripheral Actions of Melatonin on Reproduction in Seasonal and Continuous Breeding Mammals |
| Q21296744 | Clinical uses of melatonin in pediatrics |
| Q82948812 | Comparison of serum amyloid A concentrations with those of C-reactive protein and procalcitonin in diagnosis and follow-up of neonatal sepsis in premature infants |
| Q47992408 | Contribution of inducible and neuronal nitric oxide synthases to mitochondrial damage and melatonin rescue in LPS-treated mice |
| Q33790261 | Critical diaphragm failure in sudden infant death syndrome |
| Q38189661 | Delivery of pineal melatonin to the brain and SCN: role of canaliculi, cerebrospinal fluid, tanycytes and Virchow-Robin perivascular spaces |
| Q33616780 | Dietary Sources and Bioactivities of Melatonin |
| Q38254942 | Ebola virus disease: potential use of melatonin as a treatment |
| Q38328156 | Ebola virus: melatonin as a readily available treatment option. |
| Q40972743 | Effect of melatonin on the severity of L-arginine-induced experimental acute pancreatitis in rats. |
| Q46355335 | Effects of melatonin in an experimental model of ventilator-induced lung injury. |
| Q28392010 | Experimental treatments for mitochondrial dysfunction in sepsis: A narrative review |
| Q34481591 | Functions of melatonin in plants: a review. |
| Q46887509 | GH replacement reduces increased lipid peroxidation in GH-deficient adults. |
| Q33403194 | Haematological abnormalities in neonatal necrotizing enterocolitis |
| Q35562846 | Hematologic Abnormalities in Severe Neonatal Necrotizing Enterocolitis: 25 Years Later |
| Q91124813 | Immunometabolic approaches to prevent, detect, and treat neonatal sepsis |
| Q57175340 | Immunomodulation to Prevent or Treat Neonatal Sepsis: Past, Present, and Future |
| Q50947684 | Increase of placental sensitivity to melatonin and the alteration to its local synthesis in hypertensive syndromes in pregnancy. |
| Q34945493 | Inhibition of Calotropis procera latex-induced inflammatory hyperalgesia by oxytocin and melatonin |
| Q41927554 | Interplay between circadian clock and viral infection. |
| Q80565259 | Light and darkness fail to regulate melatonin release in critically ill humans |
| Q43108522 | Long-term alteration of daily melatonin, 6-sulfatoxymelatonin, cortisol, and temperature profiles in burn patients: a preliminary report |
| Q87520105 | Lower vitamin D levels are associated with increased risk of early-onset neonatal sepsis in term infants |
| Q48113846 | Maternally administered melatonin differentially regulates lipopolysaccharide-induced proinflammatory and anti-inflammatory cytokines in maternal serum, amniotic fluid, fetal liver, and fetal brain |
| Q64899186 | Melatonin Levels in Preterm and Term Infants and Their Mothers. |
| Q47940557 | Melatonin Pharmacokinetics Following Oral Administration in Preterm Neonates. |
| Q42289972 | Melatonin Pharmacological Blood Levels Increase Total Antioxidant Capacity in Critically Ill Patients |
| Q48332586 | Melatonin administration to wild-type mice and nontreated NLRP3 mutant mice share similar inhibition of the inflammatory response during sepsis. |
| Q42513420 | Melatonin ameliorates low-grade inflammation and oxidative stress in young Zucker diabetic fatty rats. |
| Q37834066 | Melatonin and cancer: current knowledge and its application to oral cavity tumours |
| Q47605395 | Melatonin and its relationship to plant hormones. |
| Q37480368 | Melatonin and reproduction revisited |
| Q46313066 | Melatonin as a mitochondria-targeted antioxidant: one of evolution's best ideas |
| Q37900675 | Melatonin as a natural ally against oxidative stress: a physicochemical examination. |
| Q55019660 | Melatonin as a new drug for improving oocyte quality. |
| Q46977123 | Melatonin attenuates phenytoin sodium-induced DNA damage |
| Q44099805 | Melatonin augments hypothermic neuroprotection in a perinatal asphyxia model |
| Q34359618 | Melatonin combats molecular terrorism at the mitochondrial level |
| Q90150868 | Melatonin for the treatment of sepsis: the scientific rationale |
| Q24186003 | Melatonin for women in pregnancy for neuroprotection of the fetus |
| Q24202969 | Melatonin for women in pregnancy for neuroprotection of the fetus |
| Q50664000 | Melatonin improves cerebrovascular function and decreases oxidative stress in chronically hypoxic lambs. |
| Q37402988 | Melatonin improves outcomes of heatstroke in mice by reducing brain inflammation and oxidative damage and multiple organ dysfunction |
| Q64911871 | Melatonin in Critically Ill Children. |
| Q64239573 | Melatonin in Hypoxic-Ischemic Brain Injury in Term and Preterm Babies |
| Q27015355 | Melatonin in perioperative medicine: Current perspective |
| Q37302940 | Melatonin in the management of perinatal hypoxic-ischemic encephalopathy: light at the end of the tunnel? |
| Q44530241 | Melatonin increases glutathione peroxidase activity and deformability of erythrocytes in septic rats |
| Q51579022 | Melatonin inhibits lipopolysaccharide-induced CC chemokine subfamily gene expression in human peripheral blood mononuclear cells in a microarray analysis. |
| Q39358136 | Melatonin modulates TLR4-mediated inflammatory genes through MyD88- and TRIF-dependent signaling pathways in lipopolysaccharide-stimulated RAW264.7 cells |
| Q44530232 | Melatonin protects against lipid peroxidation and membrane rigidity in erythrocytes from patients undergoing cardiopulmonary bypass surgery |
| Q46742288 | Melatonin protects from the long-term consequences of a neonatal hypoxic-ischemic brain injury in rats |
| Q44754252 | Melatonin protects from, but does not reverse, the effects of mediators of sepsis on liver bioenergetics |
| Q44340059 | Melatonin reduces lipid peroxidation and nitric oxide during irradiation-induced oxidative injury in the rat liver |
| Q44222454 | Melatonin reduces renal interstitial inflammation and improves hypertension in spontaneously hypertensive rats |
| Q46851688 | Melatonin reverses lipopolysaccharide-induced gastro-intestinal motility disturbances through the inhibition of oxidative stress |
| Q48457371 | Melatonin use for neuroprotection in perinatal asphyxia: a randomized controlled pilot study |
| Q36178389 | Melatonin: bone metabolism in oral cavity |
| Q36820644 | Melatonin: buffering the immune system |
| Q35145596 | Melatonin: clinical relevance |
| Q26825125 | Melatonin: its possible role in the management of viral infections--a brief review |
| Q36396126 | Melatonin: possible implications for the postoperative and critically ill patient |
| Q28194026 | Melatonin: reducing the toxicity and increasing the efficacy of drugs |
| Q43811258 | Melatonin: the next panacea? |
| Q42701983 | Microarray Analysis of Gene Expression Profiles in Response to Treatment with Melatonin in Lipopolysaccharide Activated RAW 264.7 Cells |
| Q51766339 | Mitochondria: Central Organelles for Melatonin's Antioxidant and Anti-Aging Actions. |
| Q44604266 | N1‐acetyl‐N2‐formyl‐5‐methoxykynuramine is a product of melatonin oxidation in rats |
| Q64083593 | Neonatal Vitamin D status and the risk of neonatal sepsis |
| Q35070177 | Neonatal bacterial sepsis |
| Q57405344 | Neonatal hypoxic ischaemic encephalopathy: current and future treatment options |
| Q47566352 | Neonatal outcomes of premature infants born to preeclamptic mothers. |
| Q46259477 | Neuroprotective effects of melatonin on amphetamine-induced dopaminergic fiber degeneration in the hippocampus of postnatal rats |
| Q34447222 | Neutralization of mitochondrial superoxide by superoxide dismutase 2 promotes bacterial clearance and regulates phagocyte numbers in zebrafish. |
| Q36374839 | New horizons for newborn brain protection: enhancing endogenous neuroprotection |
| Q26786753 | New means to assess neonatal inflammatory brain injury |
| Q57482211 | New prognostic biomarkers of mortality in patients undergoing liver transplantation for hepatocellular carcinoma |
| Q46943643 | Nocturnal melatonin concentration is correlated with illness severity in patients with septic disease |
| Q38817140 | On the significance of an alternate pathway of melatonin synthesis via 5-methoxytryptamine: comparisons across species |
| Q54405613 | Oral melatonin attenuates lung inflammation and airway hyperreactivity induced by inhalation of aerosolized pancreatic fluid in rats |
| Q26749245 | Oxidative Stress after Surgery on the Immature Heart |
| Q60047016 | Oxidative Stress and Neonatal Respiratory Extracorporeal Membrane Oxygenation |
| Q89031781 | Pharmacokinetics of Melatonin: The Missing Link in Clinical Efficacy? |
| Q37369312 | Pharmacokinetics of melatonin in preterm infants. |
| Q36582757 | Pharmacological utility of melatonin in the treatment of septic shock: experimental and clinical evidence |
| Q28073105 | Phenolic Melatonin-Related Compounds: Their Role as Chemical Protectors against Oxidative Stress |
| Q37260284 | Potential of immunomodulatory agents for prevention and treatment of neonatal sepsis. |
| Q37873941 | Potential utility of melatonin as an antioxidant during pregnancy and in the perinatal period |
| Q34558677 | Prognostic value of malondialdehyde serum levels in severe sepsis: a multicenter study. |
| Q34243063 | Radioiodine remnant ablation of differentiated thyroid cancer does not further increase oxidative damage to membrane lipids - early effect |
| Q34761401 | Reactive oxygen species and the hypomotility of the gall bladder as targets for the treatment of gallstones with melatonin: a review |
| Q40531704 | Relationship between vitamin D deficiency and early-onset neonatal sepsis |
| Q41622494 | Role of Oxidative Stress and Mitochondrial Dysfunction in Sepsis and Potential Therapies. |
| Q58802979 | Sepsis and Oxidative Stress in the Newborn: From Pathogenesis to Novel Therapeutic Targets |
| Q87417915 | Serum Levels of Soluble Urokinase Plasminogen Activator Receptor in Infants with Late-onset Sepsis |
| Q34451327 | Serum procalcitonin as a diagnostic marker of neonatal sepsis |
| Q89133461 | Serum total antioxidant capacity prior to liver transplantation for hepatocellular carcinoma is associated with 1-year liver transplantation survival |
| Q46691136 | Superoxide-dependent oxidation of melatonin by myeloperoxidase. |
| Q33749882 | Sustained high serum malondialdehyde levels are associated with severity and mortality in septic patients |
| Q49719878 | Systemic and transdermal melatonin administration prevents neuropathology in response to perinatal asphyxia in newborn lambs. |
| Q38117383 | Targeting oxidative stress response by green tea polyphenols: clinical implications |
| Q89509637 | The Circadian Clock, the Immune System, and Viral Infections: The Intricate Relationship Between Biological Time and Host-Virus Interaction |
| Q36253797 | The Green Tea Catechin Epigallocatechin Gallate Ameliorates Graft-versus-Host Disease |
| Q59048801 | The Potential Use of Melatonin for Preventing Cisplatin Ototoxicity: An Insight for a Clinical Approach |
| Q38675828 | The Safety of Melatonin in Humans |
| Q46007457 | The beneficial effects of melatonin against heart mitochondrial impairment during sepsis: inhibition of iNOS and preservation of nNOS. |
| Q35027014 | The chemistry of melatonin's interaction with reactive species |
| Q35753913 | The effect of MELatOnin on Depression, anxietY, cognitive function and sleep disturbances in patients with breast cancer. The MELODY trial: protocol for a randomised, placebo-controlled, double-blinded trial |
| Q46818489 | The effect of blue light exposure on the expression of circadian genes: bmal1 and cryptochrome 1 in peripheral blood mononuclear cells of jaundiced neonates |
| Q54449722 | The effect of melatonin on endotoxemia-induced intestinal apoptosis and oxidative stress in infant rats. |
| Q43604100 | The efficacy of serial serum amyloid A measurements for diagnosis and follow-up of necrotizing enterocolitis in premature infants |
| Q35864361 | The role of cytokines and inflammatory cells in perinatal brain injury |
| Q34370825 | The role of genetic polymorphisms in antioxidant enzymes and potential antioxidant therapies in neonatal lung disease |
| Q36965736 | The role of melatonin in anaesthesia and critical care |
| Q37241660 | Timing Matters: Circadian Rhythm in Sepsis, Obstructive Lung Disease, Obstructive Sleep Apnea, and Cancer |
| Q38868297 | Update on melatonin receptors: IUPHAR Review 20. |
| Q44489331 | Urgent search for safe and effective treatments of severe acute respiratory syndrome: is melatonin a promising candidate drug? |
| Q40943639 | Use of melatonin as an adjuvant therapy in neonatal sepsis |
| Q46800761 | Utility of melatonin to treat surgical stress after major vascular surgery--a safety study |
| Q38755878 | Utilizing melatonin to combat bacterial infections and septic injury. |
| Q36021253 | When melatonin gets on your nerves: its beneficial actions in experimental models of stroke |
| Q33723452 | Which neuroprotective agents are ready for bench to bedside translation in the newborn infant? |
Search more.